Skip to content

In the BioHarmony Drug Report Database

Sebelipase alfa

Kanuma (sebelipase alfa) is an enzyme pharmaceutical. Sebelipase alfa was first approved as Kanuma on 2015-08-28. It has been approved in Europe to treat inborn errors lipid metabolism.
Trade Name Kanuma
Common Name Sebelipase alfa
Indication inborn errors lipid metabolism
Drug Class Enzymes
Sebelipase alfa
Get full access now